Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
4.560
-0.050 (-1.08%)
Apr 20, 2026, 2:48 PM EDT - Market open
Cytek Biosciences Revenue
In the year 2025, Cytek Biosciences had annual revenue of $201.49M with 0.52% growth. Cytek Biosciences had revenue of $62.14M in the quarter ending December 31, 2025, with 8.12% growth.
Revenue (ttm)
$201.49M
Revenue Growth
+0.52%
P/S Ratio
2.92
Revenue / Employee
$287,027
Employees
702
Market Cap
586.19M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 201.49M | 1.04M | 0.52% |
| Dec 31, 2024 | 200.45M | 7.44M | 3.85% |
| Dec 31, 2023 | 193.02M | 28.98M | 17.67% |
| Dec 31, 2022 | 164.04M | 36.09M | 28.20% |
| Dec 31, 2021 | 127.95M | 35.11M | 37.82% |
| Dec 31, 2020 | 92.84M | 34.96M | 60.39% |
| Dec 31, 2019 | 57.88M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Varex Imaging | 854.40M |
| Orthofix Medical | 822.31M |
| Tactile Systems Technology | 329.52M |
| OrthoPediatrics | 236.35M |
| SI-BONE | 200.93M |
| Pacific Biosciences of California | 160.01M |
| Beta Bionics | 100.25M |
| NeuroPace | 99.99M |
CTKB News
- 5 weeks ago - Cytek® Biosciences Celebrates One Year of Operations at Singapore Facility, Accelerating Growth and Regional Impact - GlobeNewsWire
- 7 weeks ago - Cytek Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook - GlobeNewsWire
- 2 months ago - Cytek Biosciences to participate at the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 2 months ago - Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - GlobeNewsWire
- 3 months ago - Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results - GlobeNewsWire
- 5 months ago - TIME Recognizes Cytek® Biosciences as One of America's Growth Leaders of 2026 - GlobeNewsWire
- 5 months ago - Cytek® Muse® Micro Cell Analyzer Wins BioTech Breakthrough Award for Drug Discovery Solution of the Year - GlobeNewsWire
- 5 months ago - Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewsWire